Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy

Urinary lysophopholipids are increased in diabetic patients with nephropathy

(2017) Jean-Sébastien Saulnier-Blache et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Lysophosphatidic acid plasma concentrations in healthy subjects: circadian rhythm and associations with demographic, anthropometric and biochemical parameters

(2017) Anna Michalczyk et al.   Lipids in Health and Disease

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

(2016) Haidong Wang et al.   LANCET

Evaluation of the Biocompatibility of Dialysis Membranes

(2015) Kenichi Kokubo et al.   BLOOD PURIFICATION

Platelet Lipidomics

(2014) Valerie B. O’Donnell et al.   CIRCULATION RESEARCH

Alterations of Plasma Lysophosphatidylcholine Species in Obesity and Weight Loss

(2014) Susanne Heimerl et al.   PLoS One

Lysophosphatidylcholine, Oxidized Low-Density Lipoprotein and Cardiovascular Disease in Korean Hemodialysis Patients: Analysis at 5 Years of Follow-up

(2013) Young-Ki Lee et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Lysophosphatidic Acid Increases Proximal Tubule Cell Secretion of Profibrotic Cytokines PDGF-B and CTGF through LPA2- and Gαq-Mediated Rho and αvβ6 Integrin-Dependent Activation of TGF-β

(2012) Hui Geng et al.   AMERICAN JOURNAL OF PATHOLOGY

Quantification of plasma phospholipids by ultra performance liquid chromatography tandem mass spectrometry

(2011) Yannick Rabagny et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Lysophosphatidic Acid and Lovastatin Might Protect Kidney in Renal I/R Injury by Downregulating MCP-1 in Rat

(2011) Jin Gao et al.   RENAL FAILURE

Pharmacokinetic and Pharmacodynamic Characterization of an Oral Lysophosphatidic Acid Type 1 Receptor-Selective Antagonist

(2010) J. S. Swaney et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

The Effects of EPA, DHA, and Aspirin Ingestion on Plasma Lysophospholipids and Autotaxin

(2010) R.C. Block et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Lysophosphatidic acid and renal fibrosis

(2008) J PRADERE   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Two pathways for lysophosphatidic acid production

(2008) J AOKI   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity

(2008) S. Hosogaya et al.   ANNALS OF CLINICAL BIOCHEMISTRY